A Rowan-Virtua School of Osteopathic Medicine researcher has received a $1.925 million grant from the National Institutes of ...

A preclinical study led by the Smidt Heart Institute at Cedars-Sinai challenges the assumption that blocking the NCX1 protein ...

November 22, 2011 (Orlando, Florida) — Results from a small phase 1 study provide some reason for optimism in the treatment of ischemic cardiomyopathy with autologous cardiac stem cells (CSCs) [1].

A 'miniature human heart' created from stem cells beats on its own. Made for the drug industry, these hearts will be used to test the effects of news drugs on cardiac tissues.

Internationally-renowned cardiologist and scientist, Dr. Michael Gollob, and his research assistant Qiuju Li, conduct experiments to better understand how gene mutations change how heart cells ...

These trials, which lasted between three and six months, confirmed that the implants, which consist of 40 to 200 million heart cells, improve heart function.

By organizing the rest of the heart cell, cBIN1 helps restore critical functions of heart cells. "cBIN1 is bringing benefits to multiple signaling pathways," Li adds.

Heart muscle cells need exercise – even when they grow outside the human body. A new device designed by researchers at the University of Toronto's Faculty of Applied Science & Engineering uses a ...